WBI Investments’s ResMed RMD Stock Holding History

WBI Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$327K	Sell	1,675 -666	-28%	-$138K	0.08%	235
2026 Q1	$526K	Sell	2,341 -3,313	-59%	-$826K	0.15%	184
2025 Q4	$1.36M	Buy	5,654 +2,704	+92%	+$692K	0.36%	64
2025 Q3	$808K	Sell	2,950 -2,421	-45%	-$661K	0.21%	138
2025 Q2	$1.39M	Sell	5,371 -2,069	-28%	-$494K	0.36%	80
2025 Q1	$1.67M	Sell	7,440 -8,172	-52%	-$1.91M	0.44%	65
2024 Q4	$3.57M	Buy	15,612 +9,624	+161%	+$2.32M	0.89%	20
2024 Q3	$1.46M	Buy	+5,988	New	+$1.34M	0.35%	82
2014 Q3	–	Sell	-343,044	Closed	-$17.4M	–	213
2014 Q2	$17.4M	Buy	343,044 +8,053	+2%	+$399K	0.74%	43
2014 Q1	$15M	Buy	+334,991	New	+$15M	0.66%	46
2013 Q4	–	Sell	-205,185	Closed	-$10.8M	–	129
2013 Q3	$10.8M	Buy	+205,185	New	+$9.95M	0.52%	59

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

WBI Investments's RMD Position: Q2 2026 in Review

WBI Investments reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $138K and leaving 1,675 shares worth $327K. The position accounts for 0.08% of the portfolio, ranked #235.

WBI Investments first reported a position in RMD in Q3 2013 and has held it in 11 quarters since. The position peaked at $17.4M in Q2 2014. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

WBI Investments held 1,675 shares of ResMed worth $327K as of Q2 2026.
WBI Investments sold 666 ResMed shares in Q2 2026, an estimated $138K.
ResMed made up 0.08% of WBI Investments's portfolio in Q2 2026, its #235 holding.
WBI Investments first reported a position in ResMed in Q3 2013 and has held it in 11 quarters since.
WBI Investments's ResMed position peaked at $17.4M in Q2 2014.
888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on WBI Investments's 13F filing for Q2 2026, filed 11 Aug 2026.